BioMarin, DiNAQOR to develop gene therapies for rare genetic cardiomyopathies

BioMarin Pharmaceutical has signed a preclinical collaboration and license deal with Swiss gene therapy platform company DiNAQOR to develop novel gene therapies for the treatment ... Read More